MX9704527A - Sistema transdermico de administracion simultanea de varios principios activos. - Google Patents

Sistema transdermico de administracion simultanea de varios principios activos.

Info

Publication number
MX9704527A
MX9704527A MX9704527A MX9704527A MX9704527A MX 9704527 A MX9704527 A MX 9704527A MX 9704527 A MX9704527 A MX 9704527A MX 9704527 A MX9704527 A MX 9704527A MX 9704527 A MX9704527 A MX 9704527A
Authority
MX
Mexico
Prior art keywords
active principles
amount
therapeutic dose
effective therapeutic
active
Prior art date
Application number
MX9704527A
Other languages
English (en)
Other versions
MXPA97004527A (es
Inventor
Bruno Bevan
Cecile Aillaud
Original Assignee
Lhd Lab Hygiene Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lhd Lab Hygiene Dietetique filed Critical Lhd Lab Hygiene Dietetique
Publication of MX9704527A publication Critical patent/MX9704527A/es
Publication of MXPA97004527A publication Critical patent/MXPA97004527A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

La presente invencion se relaciona con un nuevo sistema de administracion por vía percutánea de cuando menos dos principios activos, constituido por la yuxtaposicion de cuando menos dos dispositivos, caracterizado en que comprende: (1) un primer dispositivo que contiene una mezcla del conjunto de principios activos en el cual cuando menos un primer principio activo (A) está presente segun una cantidad que permite administrar la dosis terapéutica eficaz y cuando menos un segundo principio activo (B) está presente segun una cantidad inferior a aquella que se necesita para la administracion de la dosis terapéutica eficaz; y (ii) uno o varios dispositivos suplementarios que contienen cada uno un solo principio activo (b) seleccionado entre aquellos que están presentes en el primer dispositivo segun una cantidad inferior a aquella que se necesita para la administracion de la dosis terapéutica eficaz; ese o esos dispositivo(s) suplementario(s) completa(n) la cantidad de cada uno de los principios activos (B) que están presentes en el sistema hasta obtener la dosis terapéutica eficaz.
MXPA/A/1997/004527A 1994-12-21 1995-12-19 Sistema transdermico de administracion simultaneade varios principios activos MXPA97004527A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR94/15416 1994-12-21
FR9415416A FR2728463A1 (fr) 1994-12-21 1994-12-21 Systeme transdermique d'administration simultanee de plusieurs principes actifs
FR9415416 1994-12-21
PCT/FR1995/001696 WO1996019203A1 (fr) 1994-12-21 1995-12-19 Systeme transdermique d'administration simultanee de plusieurs principes actifs

Publications (2)

Publication Number Publication Date
MX9704527A true MX9704527A (es) 1997-10-31
MXPA97004527A MXPA97004527A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
DE69506007T2 (de) 1999-06-10
EP0800386B1 (fr) 1998-11-11
AU4450596A (en) 1996-07-10
SK79197A3 (en) 1997-12-10
DK0800386T3 (da) 1999-07-26
KR980700071A (ko) 1998-03-30
FR2728463B1 (es) 1997-02-21
NO972467D0 (no) 1997-05-30
PL182452B1 (pl) 2002-01-31
AU692042B2 (en) 1998-05-28
CN1170359A (zh) 1998-01-14
SI0800386T1 (en) 1999-04-30
FI972542A0 (fi) 1997-06-16
CA2208374A1 (en) 1996-06-27
HUT77384A (hu) 1998-04-28
WO1996019203A1 (fr) 1996-06-27
CN1072929C (zh) 2001-10-17
ATE173164T1 (de) 1998-11-15
CZ183297A3 (en) 1997-10-15
HK1004375A1 (en) 1998-11-27
NZ298826A (en) 1998-10-28
NO972467L (no) 1997-06-17
DE69506007D1 (de) 1998-12-17
FI972542A (fi) 1997-06-16
UA42806C2 (uk) 2001-11-15
EP0800386A1 (fr) 1997-10-15
US5919477A (en) 1999-07-06
RU2157193C2 (ru) 2000-10-10
PL320883A1 (en) 1997-11-10
FR2728463A1 (fr) 1996-06-28
SK280631B6 (sk) 2000-05-16
ES2125679T3 (es) 1999-03-01
JPH10510823A (ja) 1998-10-20

Similar Documents

Publication Publication Date Title
AU692042B2 (en) Transdermal system for the simultaneous delivery of a number of active principles
GEP20063773B (en) Steroid Sulphatase Inhibitors
TW359613B (en) Tricot-like pouch for the delivery of topical drugs and cosmetics
ATE321529T1 (de) Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
AU2363588A (en) Plurality of tiny pills in liquid dosage form
TW347339B (en) Oral delivery of discrete units
EP1028715A4 (en) FORMULATION FOR NASAL SUPPORT AND METHOD OF USE THEREOF
IL76932A (en) Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
RU97112182A (ru) Трансдермальная система для одновременной дачи нескольких активных начал
NZ314629A (en) Use trans-splicing ribozymes to prepare medicaments for gene therapies
FI960556A (fi) Transdermaalinen aktiivisten lääkeaineiden hitaan virtauksen antojärjestelmä
AU5267698A (en) Ascending-dose dosage form
EP0233009A3 (en) System for delivering drug with enhanced bioacceptability
ES2194222T3 (es) Dispositivo para la administracion asistida electricamente de agentes tales como lidocaina y epinefrina.
IL121272A (en) Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
PL348202A1 (en) Pharmaceutically active composition and dispensing device
DE69733268D1 (de) Mittel zur transdermalen verabreichung von arzneistoffen
AU2691197A (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
DE69814669D1 (de) Pharmaceutische Zusammensetzung enthaltend (+)-EPHEDRIN und einen H1 Rezeptor Antagonisten
IL140730A0 (en) Blister pack containing transdermal therapeutic systems
MX9709013A (es) Forma de dosis que comprende oxibutinina.
IL128768A0 (en) Transdermal therapeutic system containing oestriol
GEP20043253B (en) Progestin Therapy with Controlled Bleeding